A fluorescent cell-based functional screening of niclosamide derivatives as specific inhibitors of human ABCG2
碩士 === 長庚大學 === 生物醫學研究所 === 101 === A major problem in cancer is cancer metastasis. Many metastatic cancers are resistant to treatment with a variety of structurally unrelated anti-cancer drugs, a phenomenon that is known as multidrug resistance (MDR). MDR often is mediated by ATP-binding cassette (...
Main Authors: | Hsing Wen Cheng, 鄭幸文 |
---|---|
Other Authors: | C. P. Wu |
Format: | Others |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/47162651364033822863 |
Similar Items
-
Drug screening identifies niclosamide as an inhibitor of breast cancer stem-like cells.
by: Yu-Chi Wang, et al.
Published: (2013-01-01) -
Overexpression of Human ABCB1 and ABCG2 Reduces the Susceptibility of Cancer Cells to the Histone Deacetylase 6-Specific Inhibitor Citarinostat
by: Chung-Pu Wu, et al.
Published: (2021-03-01) -
Niclosamide and its derivative DK‐520 inhibit RANKL‐induced osteoclastogenesis
by: Yurui Jiao, et al.
Published: (2020-08-01) -
Extracellular pH Modulates Neuroendocrine Prostate Cancer Cell Metabolism and Susceptibility to the Mitochondrial Inhibitor Niclosamide.
by: Joseph E Ippolito, et al.
Published: (2016-01-01) -
A fluorescent cell-based high-throughput functional screening platform for the identification of drug substrates and inhibitors of multidrug resistance-associated ATP-binding cassette proteins ABCB1 and ABCG2
by: Wei Cherng Tuo, et al.
Published: (2014)